Contract W81K0223P0126

Sebia, Inc. · Department Of Defense · August 1, 2024

Firm Fixed PriceSole SourceNAICS 325413

Sebia, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on August 1, 2024 for $287,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Joint Base Lewis Mcchord, WA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 11, 2025. If all options are exercised, the contract could reach $1.13 million.

Obligated to date
$286.7K
$286,675
Current value
$658.3K
Potential value
$1.13M
if all options exercised
Modifications
4
Latest December 11, 2025

Contract details

PIID
W81K0223P0126
Award type
Purchase Order
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Not Competed
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Place of performance
Joint Base Lewis Mcchord, WA
First action
August 1, 2024
Latest action
December 11, 2025

Description

THIS REQUIREMENT IS FOR THE FURNISHING OF ALL REAGENTS, CALIBRATORS, CONTROLS, CONSUMABLE/DISPOSABLE ITEMS, PART AND ACCESSORIES REQUIRED FOR CAPILLARY ELECTROPHORESIS AND HEMOGLOBIN A1C TESTING

Modification timeline

  • December 11, 2025
    Mod P00008 · Funding Only Action
    $658.3K
  • August 27, 2025
    Mod P00007 · Exercise An Option
    $427.4K
  • August 27, 2024
    Mod P00004 · Exercise An Option
    EXERCISING OY1, 1 OCTOBER 2024 - 30 SEPTEMBER 2025.
    $467.0K
  • August 21, 2024
    Mod P00003 · Funding Only Action
    THIS MODIFICATION IS TO PROVIDE FUNDING TO CLINS 0022 AND 0023, WHICH WAS INADVERTENTLY NOT FUNDED ON THE PREVIOUS MODIFICATION.
    $467.0K
  • August 1, 2024
    Mod P00002 · Supplemental Agreement For Work Within Scope
    0002 BASE CAPI 3 HBA1C MOD TO ADD PRODUCTS, INCREASE/DECREASE QUANTITIES AND CORRECT UNIT PRICES.
    $233.6K

Similar contracts

RecipientAgencyDateObligated
Diasorin IncDepartment Of DefenseDecember 31, 2025$518.8K
BloodworksDepartment Of DefenseDecember 31, 2025$160.2K
Sl Meditech Co.Department Of DefenseDecember 31, 2025$151.6K
Alba Bioscience, Inc.Department Of DefenseDecember 31, 2025$163.2K
Werfen USA LlcDepartment Of DefenseDecember 31, 2025$18.1K
Immucor IncDepartment Of DefenseDecember 31, 2025$154.2K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W81K0223P0126?

Contract W81K0223P0126 is a federal contract awarded to Sebia, Inc. by Department Of Defense on August 1, 2024 for $287,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.

Who won contract W81K0223P0126?

Sebia, Inc. won contract W81K0223P0126 from Department Of Defense.

How much is contract W81K0223P0126 worth?

Contract W81K0223P0126 has obligated $287,000 to date, with a total potential value of $1.13 million if all options are exercised.